His personal testimonials, combined with conversations featuring Dr
In 2023 the FDA placed BPC-157 in Category 2 of its 503A bulk-substances review the group flagged as presenting significant safety risks for compounding reflecting concerns about immunogenicity, impurities, and lack of human data
Pickart & Margolina (2018) Biomolecules : Review documenting GHK-Cu's regenerative and protective actions across skin, wound healing, lungs, and nervous system
Additionally, two small studies in participants presenting with antiretroviral-induced neuropathy found significant reduction in subjects' mean pain intensity with oral ALCAR (1-3 g/day) for 4 to 24 weeks, but no effect on objective neurophysiological parameters was found (82, 83)
Patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2) should not use semaglutide, as this is a contraindication